COMPLIMENTARY SATELLITE SYMPOSIUM


Friday, June 30, 2017
5:10 pm - 6:25 pm


Estancia La Jolla Hotel, Pacifica Ballroom

9700 North Torrey Pines Road

La Jolla, CA 92037






Program Overview
Heart Failure (HF) remains one of the principal causes of cardiovascular morbidity and mortality in America. Fortunately, novel diagnostic and treatment strategies for HF are emerging. The new therapeutics were incorporated into the 2016 Focused Update on New Pharmacological Therapy for Heart guideline. In this program, leading experts will review the diagnostic tools including biomarkers, the effects, and implications of risk factors and comorbidities on potassium levels and hyperkalemia, exist and emerge therapeutic options, and strategies for improving outcomes in patients with heart failure.

Target Audience
This activity is intended for cardiologists, cardiothoracic surgeons, and general internists interested in improving clinical outcomes in patients with hyperkalemia.

Learning Objectives
Upon completion of the educational activity, participants should be able to:

  • Review current biomarkers and their role in establishing the diagnosis and prognosis of heart failure
  • Differentiate between the type and severity of heart failure based on patient history, evaluation, and diagnostic workup
  • Review the benefits and limitations of current heart failure therapies
  • Discuss new and emerging therapies for heart failure, and their role in the therapeutic management
  • Review the effects and implications of risk factors and comorbidities on potassium levels and hyperkalemia in heart failure patients

Faculty
Barry H. Greenberg, MD
Distinguished Professor of Medicine
Director, Advanced Heart Failure Treatment Program
UC San Diego School of Medicine
La Jolla, CA

Barry H. Greenberg, MD is Distinguished Professor of Medicine and Director of the Advanced Heart Failure Treatment Program at the University of California, San Diego School of Medicine (UCSD). He serves on the executive steering and data safety monitoring committees of numerous national and international clinical trials in heart failure. He is a founding member and a past President of the Heart Failure Society of America (HFSA). Dr. Greenberg’s research interests include the basic cellular mechanisms of heart failure and the development of new forms of therapy. He has published extensively in these areas. He is co-editor of Congestive Heart Failure:

Pathophysiology, Diagnosis, and Comprehensive Approach to Management, the first comprehensive text in this field, now in its 3rd edition, and editor of Myocardial Remodeling: Mechanisms and Treatment, published in 2006, and Management of Heart Failure published in 2010. He is co-author of Contemporary Diagnosis and Management of Congestive Heart Failure. He served as an Associate Editor of the Journal of the American College of Cardiology from 2001-2014, and he sits on the editorial boards of several other cardiology specialty and subspecialty journals. Dr. Greenberg has been recognized by his peers for many years as one of the “Best Doctors in America” and “Best Doctors in San Diego.”


Agenda
5:10 PM Program Overview and Pre-Test
5:20 PM Evolving Biomarkers, Diagnosis, and the Stratification of Heart Failure
5:50 PM Strategies and Therapeutic Options for Treating Patients with Heart Failure

6:15 PM Questions, Faculty Discussion and Post-Test


CME Credit provided by AKH Inc., Advancing Knowledge in Healthcare

Physicians
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Commercial Support
This activity is supported by an educational grant from Novartis, Relyspa Inc. and ZS Pharma, Inc.

Americans with Disabilities Act
AKH Inc, Advancing Knowledge in Healthcare fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify AKH at 904-683-8843 at least two weeks prior to the activity.


If you have questions about this CME activity, please email jgoldman@akhcme.com.


*Program and faculty subject to change